[Methicillin-resistant Staphylococcus aureus--the pathogen].
Methicillin resistant Staphylococcus aureus (MRSA) are resistant to all beta-lactams, and in more than 90% to ciprofloxacin and in 50-60% also to other groups of antibiotics, glycopeptides, quinupristin and linezolid excluded. A special problem is posed by glycopeptide intermediate susceptible S. aureus (GISA) which are until now rate in Germany, By molecular typing epidemic MRSSA can be identified which have a pronounced capacity for intra- and interhospital spread. MRSA are not more but also not less virulent than sensitive S. aureus.
Witte
W
W
Robert Koch-Institut, Bereich Wernigerode, Burgstrasse 37, 38855 Wernigerode.
D003428:Cross Infection / Q000382:microbiology*; D018432:Drug Resistance, Multiple; D005858:Germany; D006801:Humans; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000472:pathogenicity; D013530:Surgical Wound Infection / Q000382:microbiology*; D014774:Virulence